India's pharmaceutical sector is projected to grow at 11-13 percent this fiscal year due to export increases. The domestic market is also e...

HDFC Pharma and Healthcare Fund recorded an impressive 25% return in the last year, surpassing its category average across various time fra...

Given the current situation both globally and domestically, one can expect more headwinds in the market. There is, on the domestic front, a...

More than 150 companies have fixed record dates for dividends and stock splits between September 21 and September 25. IRCTC, BEML, Hindusta...

The investment will help Nutriventia strengthen its research and development pipeline, expand its global commercial presence and scale its ...

As an investor, what you need to do at this point of time is this: A bit of extra work in terms of stock-picking so that you avoid anxiety ...

Mutual funds raised their healthcare allocation for the fourth straight month in August 2026 to 8.4%, the highest in 71 months. Experts att...

A major fake cancer drug racket has been busted in Karnataka, with investigators alleging that a licensed pharmacist supplied counterfeit m...

Wise men on the street will tell you it is foolish to try and time the market. And attempting to do so in the midst of a raging war is prob...

In the stock market, when a big theme or sectoral trend takes off, most investors focus on the face of it. A brand with which they can rela...

Private equity firm ChrysCapital is set to acquire a significant stake in Linux Laboratories. This deal will see existing investor Tata Cap...

Prasol Chemicals has raised nearly Rs 150 crore from anchor investors ahead of its Rs 500-crore IPO, which opens on September 8. The specia...

The CBIC has introduced a new checklist for customs officers reviewing imports. This standardized process aims to streamline clearances for...

PGIM India Healthcare Fund generated a 22% return over the past year by over-allocating to high-growth segments like CDMO, specialty pharma...

RPG Life Sciences plans to deploy Rs 500 crore over the next 12 months to expand manufacturing and API capabilities through strategic acqui...

Fosun Pharma sold a 6% stake in Gland Pharma for ₹2,800 crore via a block deal, reducing its holding to 45.77%. Major buyers included Kotak...

Indian drugmakers oppose a proposal making them solely liable for medicine overpricing. This regulatory move exempts retail chemists, hospi...